PMID- 26580221 OWN - NLM STAT- MEDLINE DCOM- 20160617 LR - 20181113 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 10 IP - 11 DP - 2015 TI - Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice. PG - e0142318 LID - 10.1371/journal.pone.0142318 [doi] LID - e0142318 AB - The destruction of beta cells in type 1 diabetes (T1D) results in loss of insulin production and glucose homeostasis. Treatment of non-obese diabetic (NOD) mice with immune-depleting/modulating agents (e.g., anti-CD3, murine anti-thymocyte-globulin (mATG)) can lead to diabetes reversal. However, for preclinical studies with these and other agents seeking to reverse disease at onset, the necessity for exogenous insulin administration is debated. Spontaneously diabetic NOD mice were treated with a short-course of mATG and insulin provided as drug therapy or by way of allogeneic islet implants. Herein we demonstrate that exogenous insulin administration is required to achieve disease reversal with mATG in NOD mice. Unexpectedly, we also observed that provision of insulin by way of allogeneic islet implantation in combination with mATG leads to a pronounced reversal of diabetes as well as restoration of tolerance to self-islets. Expansion/induction of regulatory cells was observed in NOD mice stably cured with mATG and allogeneic islets. These data suggest that transient provision of allogeneic insulin-producing islets might provide a temporary window for immune depletion to be more effective and instilling stable tolerance to endogenous beta cells. These findings support the use of a never before explored approach for preserving beta cell function in patients with recent onset T1D. FAU - Gagliani, Nicola AU - Gagliani N AD - Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy. AD - Vita-Salute San Raffaele University, Milan, Italy. FAU - Jofra, Tatiana AU - Jofra T AD - Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy. FAU - Posgai, Amanda L AU - Posgai AL AD - Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, 32610, United States of America. FAU - Atkinson, Mark A AU - Atkinson MA AD - Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, 32610, United States of America. FAU - Battaglia, Manuela AU - Battaglia M AD - Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20151118 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Antibodies, Monoclonal) RN - 0 (Antilymphocyte Serum) RN - 0 (Autoantigens) RN - 0 (Insulin) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Animals MH - Antibodies, Monoclonal/administration & dosage/immunology MH - Antilymphocyte Serum/*administration & dosage MH - Autoantigens/immunology MH - Diabetes Mellitus, Type 1/*drug therapy/immunology/physiopathology MH - Glucose/metabolism MH - Humans MH - Immune Tolerance MH - Insulin/*administration & dosage/metabolism MH - Insulin-Secreting Cells/drug effects/pathology/transplantation MH - Mice MH - Mice, Inbred NOD MH - *Transplantation, Homologous PMC - PMC4651367 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2015/11/19 06:00 MHDA- 2016/06/18 06:00 PMCR- 2015/11/18 CRDT- 2015/11/19 06:00 PHST- 2015/05/21 00:00 [received] PHST- 2015/10/19 00:00 [accepted] PHST- 2015/11/19 06:00 [entrez] PHST- 2015/11/19 06:00 [pubmed] PHST- 2016/06/18 06:00 [medline] PHST- 2015/11/18 00:00 [pmc-release] AID - PONE-D-15-21988 [pii] AID - 10.1371/journal.pone.0142318 [doi] PST - epublish SO - PLoS One. 2015 Nov 18;10(11):e0142318. doi: 10.1371/journal.pone.0142318. eCollection 2015.